AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results. The Company also updated the status of its previously announced plan to optimize certain European operations.
Fourth Quarter 2012 Summary
•Reported sales increased 5% (core sales increased 2% excluding currency and acquisition effects)
•Growth in the beauty, personal care, and beverage markets offset the anticipated softness in the generic allergy treatment market
Fourth Quarter 2012 Summary
•Reported sales increased 5% (core sales increased 2% excluding currency and acquisition effects)
•Growth in the beauty, personal care, and beverage markets offset the anticipated softness in the generic allergy treatment market
